Jad Othman

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Jad Othman

Aug 22, 2024, 16:34 | Insight

Massive NPM1m AML dataset with some possibly practice changing findings, review by Justin Kaner

Justin Kaner, Assistant Director, Hematology and Medical Oncology Fellowship Program at Weill Cornell Medicine Weill Cornell…

Aug 16, 2024, 14:19 | Insight

Talha Badar: Key takeaways from molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML

Talha Badar shared a post on X: “Molecular, clinical, and therapeutic determinants of outcome in…

May 13, 2024, 13:11 | Insight

Justin Kaner: To transplant or not to transplant…..

Justin Kaner, Assistant Professor of the Leukemia Program at Weill Cornell, shared on X: "To…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023